Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 442-451

  Wang, John H ^a   Li, Jun ^a   Wu, Qi ^a   Yang, PingAr ^a   Pawar, Rahul D ^a   Xie, Shutao ^a   Timares, Laura ^b   Raman, Chander ^a   Chaplin, David D ^c   Lu, Lu ^d   Mountz, John D ^a,e   Hsu, Hui Chen ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD1D ANTIGEN; CD23 ANTIGEN; CD69 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M; INTERFERON; SPHINGOSINE 1 PHOSPHATE; AUTOANTIGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN TRANSPORT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; C57BL 6 MOUSE; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLICULAR B CELL; GERMINAL CENTER; MARGINAL ZONE PRECURSOR B CELL; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RNA ISOLATION; SPLEEN; ANIMAL; ANTIGEN PRESENTATION; CELL MOTION; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; FOLLICULAR DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL MOVEMENT; DENDRITIC CELLS, FOLLICULAR; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GERMINAL CENTER; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; STEM CELLS;

EID: 73949122026     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900870     Document Type: Article

References (55)

1. Duan, B., H. Niu, Z. Xu, A. H. Sharpe, B. P. Croker, E. S. Sobel, and L. Morel. 2008. Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab. Invest. 88: 1008-1020.
2. Paul, E., A. Nelde, A. Verschoor, and M. C. Carroll. 2007. Follicular exclusion of autoreactive B cells requires FcgammaRIIb. Int. Immunol. 19: 365-373.
3. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395.
4. Schmidt, K. N., and J. G. Cyster. 1999. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J. Immunol. 162: 284-291.
5. Corcione, A., L. Ottonello, G. Tortolina, P. Tasso, F. Ghiotto, I. Airoldi, G. Taborelli, F. Malavasi, F. Dallegri, and V. Pistoia. 1997. Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor. Blood 90: 4493-4501. (Pubitemid 27508455)
6. Hsu, H. C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175.
7. Moratz, C., V. H. Kang, K. M. Druey, C. S. Shi, A. Scheschonka, P. M. Murphy, T. Kozasa, and J. H. Kehrl. 2000. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi a signaling responses of B lymphocytes. J. Immunol. 164: 1829-1838. (Pubitemid 30108736)
8. Chan, O., and M. J. Shlomchik. 1998. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160: 51-59. (Pubitemid 28116714)
9. Datta, S. K. 2009. Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells. Nat. Clin. Pract. Rheumatol. 5: 80-82.
10. Eisenberg, R. 2006. Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20). Endocr. Metab. Immune Disord. Drug Targets 6: 345-350.
11. Roth, R., R. J. Gee, and M. J. Mamula. 1997. B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann. N. Y. Acad. Sci. 815: 88-104.
12. Weyand, C. M., and J. J. Goronzy. 2003. Ectopic germinal center formation in rheumatoid synovitis. Ann. N. Y. Acad. Sci. 987: 140-149.
13. Bystry, R. S., V. Aluvihare, K. A. Welch, M. Kallikourdis, and A. G. Betz. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2: 1126-1132.
14. Goronzy, J. J., and C. M. Weyand. 2003. B cells as a therapeutic target in autoimmune disease. Arthritis Res. Ther. 5: 131-135.
15. Kessel, A., I. Rosner, and E. Toubi. 2008. Rituximab: beyond simple B cell depletion. Clin. Rev. Allergy Immunol. 34: 74-79.
16. Mountz, J. D., P. Yang, Q. Wu, J. Zhou, A. Tousson, A. Fitzgerald, J. Allen, X. Wang, S. Cartner, W. E. Grizzle, et al. 2005. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol. 61: 128-138.
17. Hsu, H. C., T. Zhou, H. Kim, S. Barnes, P. Yang, Q. Wu, J. Zhou, B. A. Freeman, M. Luo, and J. D. Mountz. 2006. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum. 54: 343-355.
18. Hsu, H. C., Y. Wu, P. Yang, Q. Wu, G. Job, J. Chen, J. Wang, M. A. Accavitti-Loper, W. E. Grizzle, R. H. Carter, et al. 2007. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol. 178: 5357-5365.
19. Braun, D., P. Geraldes, and J. Demengeot. 2003. Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20: 15-25.
20. Koutouzov, S., A. Mathian, and A. Dalloul. 2006. Type-I interferons and systemic lupus erythematosus. Autoimmun. Rev. 5: 554-562.
21. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197: 777-788.
22. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234.
23. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470.
24. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20: 149-157.
25. Srivastava, B., W. J. Quinn 3rd, K. Hazard, J. Erikson, and D. Allman. 2005. Characterization of marginal zone B cell precursors. J. Exp. Med. 202: 1225-1234.
26. Moratz, C., and J. H. Kehrl. 2004. In vitro and in vivo assays of B-lymphocyte migration. Methods Mol. Biol. 271: 161-171.
27. Cavanagh, L. L., A. Boyce, L. Smith, J. Padmanabha, L. Filgueira, P. Pietschmann, and R. Thomas. 2005. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res. Ther. 7: R230-R240.
28. Yao, Y., L. Richman, C. Morehouse, M. de los Reyes, B. W. Higgs, A. Boutrin, B. White, A. Coyle, J. Krueger, P. A. Kiener, et al. 2008. Type I interferon: potential therapeutic target for psoriasis? PLoS One 3: e2737.
29. Lian, Z. X., K. Kikuchi, G. X. Yang, A. A. Ansari, S. Ikehara, and M. E. Gershwin. 2004. Expansion of bone marrow IFN-α-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-a in NZB bone marrow. J. Immunol. 173: 5283-5289.
30. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
31. Hanten, J. A., J. P. Vasilakos, C. L. Riter, L. Neys, K. E. Lipson, S. S. Alkan, and W. Birmachu. 2008. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol. 9: 39.
32. Hughes, G. C., S. Thomas, C. Li, M. K. Kaja, and E. A. Clark. 2008. Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells. J. Immunol. 180: 2029-2033.
33. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
34. Wu, P., J. Wu, S. Liu, X. Han, J. Lu, Y. Shi, J. Wang, L. Lu, and X. Cao. 2008. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin. Immunol. 129: 40-48.
35. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18: 675-685.
36. Srivastava, B., R. C. Lindsley, N. Nikbakht, and D. Allman. 2005. Models for rperipheral B cell development and homeostasis. Semin. Immunol. 17: 175-182.
37. Ferguson, A. R., M. E. Youd, and R. B. Corley. 2004. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int. Immunol. 16: 1411-1422.
38. Allen, C. D., T. Okada, and J. G. Cyster. 2007. Germinal-center organization and cellular dynamics. Immunity 27: 190-202.
39. McHeyzer-Williams, L. J., D. J. Driver, and M. G. McHeyzer-Williams. 2001. Germinal center reaction. Curr. Opin. Hematol. 8: 52-59.
40. Shiow, L. R., D. B. Rosen, N. Brdicková, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
41. Cinamon, G., M. Matloubian, M. J. Lesneski, Y. Xu, C. Low, T. Lu, R. L. Proia, and J. G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5: 713-720.
42. Fazilleau, N., L. Mark, L. J. McHeyzer-Williams, and M. G. McHeyzer-Williams. 2009. Follicular helper T cells: lineage and location. Immunity 30: 324-335.
43. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62.
44. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1: 31-36.
45. Pernis, A. B. 2009. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J. Intern. Med. 265: 644-652.
46. Yang, J., Y. Chu, X. Yang, D. Gao, L. Zhu, X. Yang, L. Wan, and M. Li. 2009. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 60: 1472-1483.
47. Zhao, X. F., H. F. Pan, H. Yuan, W. H. Zhang, X. P. Li, G. H. Wang, G. C. Wu, H. Su, F. M. Pan, W. X. Li, et al. 2009. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep. In press.
48. Moschen, A. R., S. Geiger, I. Krehan, A. Kaser, and H. Tilg. 2008. Interferon-α controls IL-17 expression in vitro and in vivo. Immunobiology 213: 779-787.
49. Asselin-Paturel, C., G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201: 1157-1167.
50. Ayad, N. G., S. Rankin, M. Murakami, J. Jebanathirajah, S. Gygi, and M. W. Kirschner. 2003. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113: 101-113.
51. Ruchaud, S., M. Carmena, and W. C. Earnshaw. 2007. The chromosomal passenger complex: one for all and all for one. Cell 131: 230-231.
52. Schmitz, J., E. Watrin, P. Lénárt, K. Mechtler, and J. M. Peters. 2007. Sororin is required for stable binding of cohesin to chromatin and for sister chromatid cohesion in interphase. Curr. Biol. 17: 630-636.
53. Rubtsov, A. V., C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres. 2008. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J. Immunol. 180: 3882-3888.
54. McHeyzer-Williams, L. J., N. Pelletier, L. Mark, N. Fazilleau, and M. G. McHeyzer-Williams. 2009. Follicular helper T cells as cognate regulators of B cell immunity. Curr. Opin. Immunol. 21: 266-273.
55. Batista, F. D., and N. E. Harwood. 2009. The who, how and where of antigen presentation to B cells. Nat. Rev. Immunol. 9: 15-27.